(Reuters) - Vectura Group said on Friday a British court had ruled in its favor on the packaging of a generic version of an inhaler made by bigger rival GlaxoSmithKline. Vectura said the court ...

A major pharmaceutical company which alleges trademark infringement has been refused an injunction preventing the roll-out by a rival of an inhaler for asthmatics. The injunction was sought pending ...

Pharmaceutical firm Cipla Ltd on Friday said it is voluntarily recalling six batches of Albuterol Sulfate inhalation aerosol in the US market due to container defect. Cipla Ltd, India's fourth-largest ...

Mumbai: Glenmark Pharmaceuticals Ltd said on Friday that it has received regulatory approval for the generic version of GlaxoSmithKline Plc’s Seretide Accuhaler in the Nordic region, which includes ...

A major pharmaceutical company has claimed alleged infringement of its trademark entitles it to an injunction preventing the roll-out by a rival of an inhaler for asthmatics. GlaxoSmithKline (GSK) ...

Enters the inhaler market in Russia with approval of Salmecort MDI inhaler Glenmark Pharmaceuticals has received approval for Salmecort (Salmeterol+Fluticasone) MDI inhaler, from the Ministry of ...

The New England Journal of Medicine has published a clinical trial showing that Novartis' Ultibro Breezhaler outshone GlaxoSmithKline's Seretide on reducing COPD flare-ups, which could challenge the ...

Two brands have been recalled for failing to deliver the right doses of potentially life-saving medication. ASTHMA sufferers have been told to check their inhalers out after two brands issued an ...

Introduction: The incidence of asthma exacerbations in patients receiving salmeterol/fluticasone propionate (Seretide™ or Advair ®) is low. However, when asthma control deteriorates, clinicians may ...

Seretide/Advair is GSK’s best-selling drug, and the line was extended in 2003 when the European Union approved the higher-dose 500 Accuhaler for the symptomatic treatment of severe COPD, i.e., ...

AN URGENT inhaler recall has been issued for asthma sufferers with GPs warning they are failing to deliver the correct doses of medication, putting people's lives "at risk". The Medicines and ...